The alarmin, interleukin‐33, increases vascular tone via extracellular signal regulated kinase‐mediated Ca2+ sensitization and endothelial nitric oxide synthase inhibition

Evan DeVallance,Elizabeth Bowdridge,Krista Garner,Julie Griffith,Madison Seman,Thomas Batchelor,Murugesan Velayutham,W. Travis Goldsmith,Salik Hussain,Eric E. Kelley,Timothy R. Nurkiewicz

DOI: https://doi.org/10.1113/jp286990

2024-11-19

The Journal of Physiology

Abstract:figure legend A proposed model for interleukin (IL)‐33 vascular regulation is shown. Top: the known physiological sources of IL‐33 as both lung and vascular injury have been reported to release IL‐33. Bottom: the proposed cellular mechanism through which IL‐33 acts on vascular cells. IL‐33 activation of extracellular signal regulated kinase (ERK)1/2 (probably through its canonical ST2 receptor) leads to opposition of nitric oxide‐mediated dilatation through inhibitory phosphorylation at serine 602. In the smooth muscle, IL‐33 acting through a MyD88‐ERK1/2‐dependent pathway leads to increases in feed artery tone through Ca2+ sensitization. These actions suggest that IL‐33 released from barrier cell injury acts to limit blood flow and promote healing of injured sites. Alarmins are classified by their release from damaged or ruptured cells. Many alarmins have been found to increase vascular tone and oppose endothelium‐dependent dilatation (EDD). Interleukin (IL)‐33 plays a prominent role in lung injury and can be released during vascular injury and in chronic studies found to be cardioprotective. Our recent work has implicated IL‐33 in acute vascular dysfunction following inhalation of engineered nanomaterials (ENM). However, the mechanisms linking IL‐33 to vascular tone have not been interrogated. We therefore aimed to determine whether IL‐33 directly influenced microvascular tone and endothelial function. Isolated feed arteries and in vivo arterioles from male and female Sprague–Dawley rats were used to determine direct vascular actions of IL‐33. Mesenteric feed arteries and arterioles demonstrated reduced intraluminal diameters when treated with increasing concentrations of recombinant IL‐33. IL‐33 activated extracellular signal regulated kinase (ERK)1/2 of rat aortic smooth muscle cells but not phosphorylation of myosin light chain kinase. This suggested IL‐33 may sensitize arterioles to Ca2+‐mediated responses. Indeed, IL‐33 augmented the myogenic‐ and phenylephrine‐induced vasoconstriction. Additionally, incubation of arterioles with 1 ng IL‐33 attenuated ACh‐mediated EDD. Mechanistically, in human aortic endothelial cells, we demonstrate that IL‐33‐mediated ERK1/2 activation leads to inhibitory phosphorylation of serine 602 on endothelial nitric oxide synthase. Finally, we demonstrate that IL‐33‐ERK1/2 contributes to vascular tone following two known inducers of IL‐33; ENM inhalation and the rupture endothelial cells. The present study provides novel evidence that IL‐33 increases vascular tone via canonical ERK1/2 activation in microvascular smooth muscle and endothelium. Altogether, it is suggested IL‐33 plays a critical role in microvascular homeostasis following barrier cell injury. Key points Interleukin (IL)‐33 causes a concentration‐dependent reduction in feed artery diameter. IL‐33 acts on vascular smooth muscle cells to augment Ca2+‐mediated processes. IL‐33 causes inhibitory phosphorylation of endothelial nitric oxide synthase and opposes endothelium‐dependent dilatation. Engineered nanomaterial‐induced lung injury and endothelial cell rupture in part act through IL‐33 to mediate increased vascular tone.

neurosciences,physiology